Monkey

Monkey Adverse Event Insights

The FDA Center for Veterinary Medicine database holds 50 adverse event reports for Monkey, distributed across 3 distinct breeds currently tracked in the system. Of those reports, 8 involved a death outcome — producing a 1600.0% case-fatality rate among reported events, which reflects reporting severity bias rather than true population mortality. These figures are aggregated directly from openFDA's Animal & Veterinary Adverse Events endpoint and update as new voluntary submissions flow through pet owners, veterinarians, and drug manufacturers.

The most frequently reported clinical signs for Monkey are Lack of efficacy - NOS (13 reports), Injection site swelling (8 reports), INEFFECTIVE, ANESTHESIA (6 reports), Bradycardia (4 reports), with Lack of efficacy - NOS leading the reaction traffic at 13 submissions. On the product side, Ketamine Hydrochloride is the single most-referenced drug with 16 reports, followed by Ketamine Hcl (9), Desoxycorticosterone Pivalate (7), Isoflurane (5). This combination surfaces which therapeutic classes generate the most adverse event chatter for this species — a useful starting point when comparing Monkey reporting patterns against other companion animals in the dataset.

Of the 33 Monkey reports with a coded outcome, Recovered/Normal accounts for the largest share at 57.6%. Annual submission volume spans 2,010 to 2,024 reports across the 14 years on file, a range that reflects evolving owner awareness, veterinary reporting habits, and new product approvals rather than stable underlying incidence. The breed-level table below breaks these patterns down further, showing how the 3 tracked monkey breeds compare on volume, deaths, and average age at report. As with all FDA adverse event data, correlation is the ceiling — causation requires clinical investigation beyond what these aggregates can provide.